Butterfly Network (BFLY) Supplements Core Business With Additional Revenue Stream

Butterfly Network Inc. (NYSE:BFLY) is one of the 11 most popular AI penny stocks to buy now. On February 27, TD Cowen increased the firm’s price target on Butterfly Network Inc. (NYSE:BFLY) to $6 from $4.50. The firm maintained its Buy rating on the shares, which now yield more than 64% upside potential.

TD Cowen reflected on the company’s strong fourth-quarter results, which are a key factor supporting its outlook. According to the firm, Butterfly Embedded is expected to become an increasingly important part of the company’s overall story as it develops into an additional revenue stream alongside the core POCUS business. The firm believes that as this platform expands, it could turn the company into more of a tech player rather than a pure play medical technology business.

On February 26, Butterfly Network Inc. (NYSE:BFLY) reported Q4 revenue of $31.5 million, compared to $22.4 million last year. CEO Joseph DeVivo stated that the fourth quarter demonstrated strategic progress, with record topline figures reflecting 41% year-over-year growth.

Butterfly Network Inc. (NYSE:BFLY) is evolving its strategy from being a medical device company to a semiconductor-based company focused on AI-native imaging. The company is expanding enterprise adoption, commercializing HomeCare, and opening new applications through Butterfly Embedded. All of this is powered by the same proprietary Ultrasound-on-Chip technology, consolidating a unified strategy to execute and win.

Butterfly Network Inc. (NYSE:BFLY) is engaged in the development and commercialization of ultrasound imaging solutions worldwide. It delivers innovative, whole-body imaging on a single handheld probe through its Butterfly iQ+ and iQ3 ultrasound devices. Other offerings include Butterfly Move, iQ+ Bladder, Compass AI, and ScanLab.